Alkermes’ Corporate Presentation to be Webcast at the Morgan Stanley Global Healthcare Conference
07 September 2016 - 6:00AM
Business Wire
Alkermes plc (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live at the Morgan Stanley Global
Healthcare Conference on Monday, Sept. 12, 2016, at 1:40 p.m. EDT
(6:40 p.m. BST) from the Grand Hyatt New York. The presentation may
be accessed under the Investors tab on www.alkermes.com and will be
archived for 14 days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing
facility in Wilmington, Ohio. For more information, please visit
Alkermes’ website at www.alkermes.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160906006370/en/
AlkermesSandra Coombs, +1 781-609-6377Corporate
Communications
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Apr 2024 to May 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From May 2023 to May 2024